ES2094537T3 - Prevencion de adherencias de tejidos usando la modificacion de alginato in situ. - Google Patents

Prevencion de adherencias de tejidos usando la modificacion de alginato in situ.

Info

Publication number
ES2094537T3
ES2094537T3 ES93908588T ES93908588T ES2094537T3 ES 2094537 T3 ES2094537 T3 ES 2094537T3 ES 93908588 T ES93908588 T ES 93908588T ES 93908588 T ES93908588 T ES 93908588T ES 2094537 T3 ES2094537 T3 ES 2094537T3
Authority
ES
Spain
Prior art keywords
situ
prevention
articular
alginate
modified material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93908588T
Other languages
English (en)
Inventor
Harold M Aberman
James J Barry
Paul A Higham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MTG Divestitures LLC
Original Assignee
Howmedica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howmedica Inc filed Critical Howmedica Inc
Application granted granted Critical
Publication of ES2094537T3 publication Critical patent/ES2094537T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

UN METODO PARA MODIFICAR IN SITU LAS SALES DE UN ACIDO ALGINICO PARA LA PREVENCION Y TRATAMIENTO DE VARIAS COMPLICACIONES INTRAARTICULARES Y EXTRA-ARTICULARES ((DE LA ESPINA DORSAL) SEGUN EL CUAL SE MODIFICA IN SITU EL ALGINATO HASTA OBTENER UN GEL INSOLUBLE. CON ESTA MODIFICACION IN SITU SE OBTIENE UN PRODUCTO FINAL QUE SE PUEDE COMPRIMIR DENTRO DEL ESPACIO INTRA-ARTICULAR CON LO QUE PERMANECE LOCALIZADO. EL MATERIAL MODIFICADO PUEDE TENER RESISTENCIAS MECANICAS DIVERSAS Y POR TANTO MOMENTOS DE DEGRADACION DIVERSOS Y PUEDE ACTUAR COMO MATRIZ PARA LA LOCALIZACION Y LIBERACION LENTA DE AGENTES TERAPEUTICOS. EL MATERIAL MODIFICADO ES BIOCOMPATIBLE Y BIODEGRADABLE, POR LO QUE NO ES NECESARIA UNA REOPERACION PARA SU RETIRADA.
ES93908588T 1992-06-30 1993-04-02 Prevencion de adherencias de tejidos usando la modificacion de alginato in situ. Expired - Lifetime ES2094537T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/906,953 US5266326A (en) 1992-06-30 1992-06-30 In situ modification of alginate

Publications (1)

Publication Number Publication Date
ES2094537T3 true ES2094537T3 (es) 1997-01-16

Family

ID=25423289

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93908588T Expired - Lifetime ES2094537T3 (es) 1992-06-30 1993-04-02 Prevencion de adherencias de tejidos usando la modificacion de alginato in situ.

Country Status (11)

Country Link
US (1) US5266326A (es)
EP (1) EP0648122B1 (es)
JP (1) JPH07504682A (es)
AT (1) ATE145331T1 (es)
AU (1) AU671114B2 (es)
CA (1) CA2139311A1 (es)
DE (1) DE69306114T2 (es)
DK (1) DK0648122T3 (es)
ES (1) ES2094537T3 (es)
GR (1) GR3022093T3 (es)
WO (1) WO1994000134A1 (es)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
DE69426530D1 (de) * 1993-10-04 2001-02-08 Maurizio Tonetti Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
US5931165A (en) * 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
US6150581A (en) * 1995-06-07 2000-11-21 United States Surgical Corporation Chitosan/alginate anti-adhesion barrier
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
US6869938B1 (en) 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US5906997A (en) * 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US20040096422A1 (en) * 1997-06-17 2004-05-20 Schwartz Herbert E. Compositions of polyacids and polyethers and methods for their use in reducing pain
US20050074495A1 (en) * 1997-06-17 2005-04-07 Fziomed, Inc. Compositions of polyacids and methods for their use in reducing adhesions
US7192984B2 (en) * 1997-06-17 2007-03-20 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use as dermal fillers
CA2212300A1 (en) 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
US6514534B1 (en) 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
US6632457B1 (en) 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US6302848B1 (en) 1999-07-01 2001-10-16 Sonotech, Inc. In vivo biocompatible acoustic coupling media
KR20010010151A (ko) * 1999-07-16 2001-02-05 김윤 수용성 알긴산염과 카르복시메틸 셀룰로오스를 주성분으로 하는 유착방지제 및 그의 제조방법
WO2001036000A1 (en) 1999-11-15 2001-05-25 Bio Syntech Canada, Inc. Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
WO2001037802A1 (en) * 1999-11-29 2001-05-31 Advanced Research And Technology Institute, Inc. Sustained percutaneous delivery of a biologically active substance
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
AU1848601A (en) * 1999-12-09 2001-06-18 Bio Syntech Canada Inc Mineral-polymer hybrid composition
US6566345B2 (en) 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
US6638917B1 (en) 2000-02-25 2003-10-28 Scimed Life Systems, Inc. Reducing adhesion
GB0005743D0 (en) * 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates
US20020010150A1 (en) * 2000-04-28 2002-01-24 Cortese Stephanie M. Homostatic compositions of polyacids and polyalkylene oxides and methods for their use
KR20010107067A (ko) * 2000-05-25 2001-12-07 김정식 유착방지제
JP5089006B2 (ja) 2000-06-29 2012-12-05 ピラマル ヘルスケア （カナダ） リミテッド 軟骨および他の組織の修復および再生のための組成物および方法
DE60125973D1 (de) * 2000-11-15 2007-02-22 Biosyntech Canada Inc Verfahren zur wiederherstellung einer geschädigten bandscheibe
US6989373B2 (en) * 2000-11-15 2006-01-24 Bio Syntech Canada Inc. Method for restoring a fat-pad
ES2353116T3 (es) * 2002-07-16 2011-02-25 Bio Syntech Canada Inc. Composiciones para disoluciones de quitosano citocompatibles, inyectables, autogelificantes para encapsular y administrar células vivas o factores biológicamente activos.
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
EP1603579A4 (en) * 2003-03-10 2006-06-14 Univ Michigan COMPOSITIONS AND METHODS OF USE OF ALGINATE DURAL SEALANTS
EP1631265A2 (en) * 2003-05-30 2006-03-08 Arc Pharmaceuticals, Inc. Use of various agents for inhibiting fibrous adhesions
US20050118206A1 (en) * 2003-11-14 2005-06-02 Luk Andrew S. Surfactant-based gel as an injectable, sustained drug delivery vehicle
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
US8062272B2 (en) 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
GB0409446D0 (en) 2004-04-28 2004-06-02 Smith & Nephew Apparatus
MX2007004261A (es) * 2004-10-12 2007-06-18 Fmc Biopolymer As Sistemas de alginato auto-gelificantes y usos de los mismos.
US8663225B2 (en) 2004-11-12 2014-03-04 Medtronic, Inc. Hydrogel bone void filler
US20090149421A1 (en) * 2005-11-04 2009-06-11 Bio Syntech Canada Inc. Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state
DE102006029500A1 (de) * 2006-06-27 2008-01-03 Schulz, Hans H. Verwendung einer antimikrobiellen härtenden Alginatmasse zur topischen Behandlung von Wunden und Entzündungen in der Human-, Zahn- und Veterinärmedizin
US20080187568A1 (en) * 2007-02-06 2008-08-07 Sawhney Amarpreet S Polymerization with precipitation of proteins for elution in physiological solution
JP4740369B2 (ja) 2007-02-21 2011-08-03 持田製薬株式会社 軟骨疾患治療用組成物
CN101918007B (zh) * 2007-08-28 2014-06-04 Fmc有限公司 延迟的自胶凝藻酸盐体系及其应用
CA2705850C (en) * 2007-11-13 2016-07-19 Bio-Technology General (Israel) Ltd. Dilute filtration sterilization process for viscoelastic biopolymers
US20090149746A1 (en) * 2007-11-19 2009-06-11 Rubicor Medical, Inc. Post-biopsy cavity treatment implants and methods
HUE043133T2 (hu) 2007-11-21 2019-07-29 Smith & Nephew Sebkötözés
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
ES2555204T3 (es) 2007-11-21 2015-12-29 T.J. Smith & Nephew Limited Dispositivo de succión y venda
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US20130096518A1 (en) 2007-12-06 2013-04-18 Smith & Nephew Plc Wound filling apparatuses and methods
ITRM20080037A1 (it) * 2008-01-23 2009-07-24 Uni Degli Studi Perugia Procedimento per la ultrapurificazione di alginati.
US8668863B2 (en) 2008-02-26 2014-03-11 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
EP2095832A1 (de) 2008-02-28 2009-09-02 Bayer MaterialScience AG Polyharnstoff-Systeme und deren Anwendung als postoperative Adhäsionsbarrieren, Filme und Verbundteile.
DE102008022086A1 (de) * 2008-05-05 2009-11-12 Schulz, Hans H. Zweikomponenten-Alginat
US8367637B2 (en) * 2008-08-19 2013-02-05 Mochida Pharmaceutical Co., Ltd. Composition for treating arthritic disorder
CN102395401B (zh) * 2009-02-12 2015-08-19 因赛普特有限责任公司 经由水凝胶塞的药物递送
GB0902816D0 (en) 2009-02-19 2009-04-08 Smith & Nephew Fluid communication path
US8252317B2 (en) * 2009-02-26 2012-08-28 General Electric Company Metal alginate hydrogel and articles thereof
WO2010117266A1 (en) 2009-04-06 2010-10-14 Broockeville Corporation N.V. In situ gelling alginate systems
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
WO2012048289A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
WO2012048283A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
CN107033596A (zh) 2010-11-25 2017-08-11 史密夫及内修公开有限公司 组合物i – ii及其产品和用途
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
RU2463986C2 (ru) * 2010-12-13 2012-10-20 Федеральное государственное бюджетное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНЦ "ВТО" им. акад. Г.А. Илизарова" Минздравсоцразвития России) Способ стимуляции репаративных процессов при лечении внутрисуставных переломов
MY175309A (en) * 2011-11-25 2020-06-18 Otsuka Pharma Factory Inc Pharmaceutical composition useful for adhesion prevention or hemostasis
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
EP2612846A1 (de) 2012-01-09 2013-07-10 Bayer MaterialScience AG Beta-Aminosäureester und deren Verwendung
EP2931327B1 (en) 2012-12-11 2019-02-13 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
US9993497B2 (en) * 2012-12-30 2018-06-12 Hadasit Medical Research Services And Development Ltd. Use of alginate compositions in preventing or reducing liver damage caused by a hepatotoxic agent
EP2968647B1 (en) 2013-03-15 2022-06-29 Smith & Nephew plc Wound dressing sealant and use thereof
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
ES2864658T3 (es) 2014-05-05 2021-10-14 Advanced Medical Solutions Israel Sealantis Ltd Adhesivos y selladores biológicos y métodos de uso de los mismos
SG11201609593RA (en) * 2014-05-16 2016-12-29 Ultrast Inc Phase-shifting formulations
US11980700B2 (en) 2017-03-08 2024-05-14 Alafair Biosciences, Inc. Hydrogel medium for the storage and preservation of tissue
CN113521398A (zh) * 2021-08-10 2021-10-22 青岛琛蓝海洋生物工程有限公司 一种原位可注射防粘连凝胶及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57167919A (en) * 1981-04-07 1982-10-16 Hirozo Ohira Preventing agent for intraperitoneal adhesion
CA1202904A (en) * 1983-11-21 1986-04-08 Brian G. Sparkes Chitosan based wound dressing materials
DE3601132A1 (de) * 1986-01-16 1987-07-23 Christian Bannert Verfahren zur behandlung der schleimhaut
US4948575A (en) * 1989-01-24 1990-08-14 Minnesota Mining And Manufacturing Company Alginate hydrogel foam wound dressing
GB8911177D0 (en) * 1989-05-16 1989-07-05 Vilain Jean Alginate gel pharmaceutical product
US4994277A (en) * 1989-10-31 1991-02-19 Pfizer Hospital Products Group, Inc. Use of xanthan gum for preventing adhesions
US5093319A (en) * 1989-10-31 1992-03-03 Pfizer Hospital Products Group, Inc. Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions

Also Published As

Publication number Publication date
DK0648122T3 (da) 1996-12-09
AU3935693A (en) 1994-01-24
GR3022093T3 (en) 1997-03-31
DE69306114T2 (de) 1997-03-13
EP0648122B1 (en) 1996-11-20
CA2139311A1 (en) 1994-01-06
AU671114B2 (en) 1996-08-15
JPH07504682A (ja) 1995-05-25
EP0648122A1 (en) 1995-04-19
DE69306114D1 (de) 1997-01-02
WO1994000134A1 (en) 1994-01-06
ATE145331T1 (de) 1996-12-15
US5266326A (en) 1993-11-30

Similar Documents

Publication Publication Date Title
ES2094537T3 (es) Prevencion de adherencias de tejidos usando la modificacion de alginato in situ.
GR3030429T3 (en) Method for the treatment of bone tissues and implantable biomaterials thereof.
DE69521118D1 (de) Verbessertes verfahren zur fixierung von verkalkungsbestendigen biologischen geweben
CA2070586A1 (en) Prosthetic Implant
ES8600613A1 (es) Procedimiento para el tratamiento de tejidos corporales
BR9407992A (pt) Método para melhorar as reaçoes biológicas a um dispositivo que é cirurgicamente implantável em osso vivo dispositivo protético cirurgicamente implantável em osso vivo implante dental substancialmente cilíndrico método para aumentar a retençao mecânica de um dispositivo que é cirurgicamente implantável em osso vivo
ATE242960T1 (de) Vorrichtung und verfahren zur photoaktivierung
SE9804183D0 (sv) Biocompatible glue
NO924697D0 (no) Kirurgisk implantat og en fremgangsmaate for behandling avkirurgisk implantat
AU5056196A (en) Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof
DE69333658D1 (de) Verfahren zur behandlung von organen und gewebe
ZA907056B (en) Laser light irradiation apparatus
IL115721A (en) Device for the modulation of cell proliferation and wound healing and methods for its preparation
NO921454D0 (no) Fremgangsmaater og blandinger for heling av ben
DE69943067D1 (de) Verwendung von dreidimensionalen Prothesen, die Hyaluronsäurederivate enthalten
CA2101435A1 (en) Method and apparatus for declawing poultry
AR004492A1 (es) Cabello artificial para implante y procedimiento para producir el mismo
ES2014843A6 (es) Matriz de crecimiento oseo y procedimiento para su fabricacion.
DK288490D0 (da) Implantation og metode hertil
HU885915D0 (en) Process for the production of medical preparations for reducing intraocular pressure
EP0276836A3 (en) Implant material and method of producing the same
EP0968729A3 (en) Bone regeneration material
DE69937892D1 (de) Implantatmaterial
RU2116763C1 (ru) Способ лечения синовиальных кист
Saha Tissue engineered successful reconstruction of a complex traumatized lower extremity

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 648122

Country of ref document: ES